{
    "nct_id": "NCT06323928",
    "official_title": "Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments",
    "inclusion_criteria": "* The participant has a diagnosis of migraine as defined by International Classification of Headache Disorders Third Edition (ICHD-3) guidelines confirmed at the Screening Visit.\n* The participant has a history of migraine onset ≥ 12 months prior to the Screening Visit.\n* The participant has a migraine onset at ≤50 years of age.\n* The participant has ≥4 migraine days per month for each month within the past 3 months prior to the Screening Visit.\n* The participant has documented evidence of treatment failure in the past 10 years of at least 1 to 4 (maximum) different migraine preventive medications.\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* The participant has previously been dosed with an anti-pituitary adenylate cyclase-activating peptide (anti-PACAP treatment).\n* The participant has confounding and clinically significant pain syndromes.\n* The participant has a diagnosis of acute or active temporomandibular disorder.\n* The participant has a history or diagnosis of confounding headaches.\n\nAdditional protocol-defined criteria apply.",
    "miscellaneous_criteria": "Key"
}